Nilox Midi (Nitroxoline)

Nitroxoline, the active ingredient in Nilox Midi, is a quinoline antibacterial presented as an oral tablet for oral use. It treats urinary tract infections in adult patients. GNH USA supplies Nilox Midi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nitroxoline is used to manage infections of the urinary tract by targeting bacterial growth. - Uncomplicated urinary tract infection: reduces bacterial load and alleviates symptoms. - Complicated urinary tract infection: assists in clearing infection when anatomical or functional abnormalities are present. - Recurrent urinary tract infection: helps prevent further episodes by eradicating persistent pathogens. - Prophylaxis of urinary infections in susceptible patients: provides ongoing antimicrobial protection during high‑risk periods.

Nitroxoline may cause several adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nausea - Dyspepsia - Headache - Dizziness

Serious or Rare Side Effects: - Hepatic dysfunction (elevated transaminases) - Severe allergic reactions, including anaphylaxis

Before prescribing Nitroxoline, clinicians should consider several safety factors. - Renal function: assess baseline kidney function and monitor during therapy. - Hepatic function: evaluate liver enzymes prior to initiation. - Allergy: avoid use in patients with known hypersensitivity to quinoline derivatives. - Pregnancy: prescribe only if the potential benefit justifies the potential risk to the fetus. - Drug interactions: review concomitant medications for possible interactions. - Store at ambient temperature: keep in the original container, protect from moisture and heat.

Nitroxoline can interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Iron supplements: chelation reduces nitroxoline absorption. - Anticoagulants: may potentiate bleeding risk. - Probenecid: can increase nitroxoline plasma concentrations.

Moderate Interactions (Monitor Closely): - NSAIDs: may increase risk of renal impairment. - Diuretics: monitor electrolyte balance and renal function. - Sulfonamides: additive irritation of the urinary tract may occur.